User:Meditrix

There's a mistake (at least one) in this article. The text discussing strontium reads as follows:

"Oral strontium ranelate is an alternative oral treatment, belonging to a class of drugs called 'dual action bone agents' (DABAs) by its manufacturer. It has proven efficacy, especially in the prevention of vertebral fracture.[35] In laboratory experiments, strontium ranelate was noted to stimulate the proliferation of osteoblasts, as well as inhibiting the proliferation of osteoclasts."

But the reference cited, #35, refers to the prevention of NONvertebral fractures.